Affinity Biosensors

LifeScale AST System: Rapid Antimicrobial Susceptibility Testing Same-day reporting from positive blood cultures RAPID ANTIMICROBIAL SUSCEPTIBILITY TESTING POPULATION PROFILING DELAYED-GROWTH PHENOTYPES RAPID and PRECISE COUNTS and MASS MEASUREMENT OF INDIVIDUAL MICROBES LOW SAMPLE VOLUME AND CONCENTRATIONS Affinity Biosensors has developed the LifeScale AST system which utilizes mass sensing technology to produce a phenotypic AST result for Gram-negative bacteria directly from a positive blood culture bottle in ~ 4.5 hours. The Companys patented microfluidic sensor measures the mass of individual microbes at the femtogram level. The touchscreen-driven workflow requires minimal hands-on time by the technologist. MIC results are reported as well...

Rapid antimicrobial susceptibility testing,population profiling,and delayed-growth phenotypes

Affinity biosensors operates in the Medical equipment manufacturing industry.

Affinity biosensors's revenue is 11m - 100m

Affinity biosensors has 11 - 50 employees.